Prostate cancer reporting and staging

needle biopsy and radical prostatectomy specimens

Research output: Contribution to journalArticle

Abstract

Prostatic adenocarcinoma remains the most common cancer affecting men. A substantial majority of patients have the diagnosis made on thin needle biopsies, most often in the absence of a palpable abnormality. Treatment choices ranging from surveillance to radical prostatectomy or radiation therapy are largely driven by the pathologic findings in the biopsy specimen. The first part of this review focuses on important morphologic parameters in needle biopsy specimens that are not covered in the accompanying articles. This includes tumor quantification as well as other parameters such a extraprostatic extension, seminal vesicle invasion, perineural invasion, and lymphovascular invasion. For those men who undergo radical prostatectomy, pathologic stage and other parameters are critical in prognostication and in determining the appropriateness of adjuvant therapy. Staging parameters, including extraprostatic extension, seminal vesicle invasion, and lymph node status are discussed here. Surgical margin status is also an important parameter and definitions and reporting of this feature are detailed. Throughout the article the current reporting guidelines published by the College of American Pathologists and the International Collaboration on Cancer Reporting are highlighted.

Original languageEnglish (US)
Pages (from-to)S96-S109
JournalModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Volume31
Issue numberS1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Neoplasm Staging
Needle Biopsy
Prostatectomy
Prostatic Neoplasms
Seminal Vesicles
Neoplasms
Adenocarcinoma
Radiotherapy
Lymph Nodes
Guidelines
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{be79ddf4a2124cbd8d54a903949675a3,
title = "Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens",
abstract = "Prostatic adenocarcinoma remains the most common cancer affecting men. A substantial majority of patients have the diagnosis made on thin needle biopsies, most often in the absence of a palpable abnormality. Treatment choices ranging from surveillance to radical prostatectomy or radiation therapy are largely driven by the pathologic findings in the biopsy specimen. The first part of this review focuses on important morphologic parameters in needle biopsy specimens that are not covered in the accompanying articles. This includes tumor quantification as well as other parameters such a extraprostatic extension, seminal vesicle invasion, perineural invasion, and lymphovascular invasion. For those men who undergo radical prostatectomy, pathologic stage and other parameters are critical in prognostication and in determining the appropriateness of adjuvant therapy. Staging parameters, including extraprostatic extension, seminal vesicle invasion, and lymph node status are discussed here. Surgical margin status is also an important parameter and definitions and reporting of this feature are detailed. Throughout the article the current reporting guidelines published by the College of American Pathologists and the International Collaboration on Cancer Reporting are highlighted.",
author = "David Grignon",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/modpathol.2017.167",
language = "English (US)",
volume = "31",
pages = "S96--S109",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "S1",

}

TY - JOUR

T1 - Prostate cancer reporting and staging

T2 - needle biopsy and radical prostatectomy specimens

AU - Grignon, David

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Prostatic adenocarcinoma remains the most common cancer affecting men. A substantial majority of patients have the diagnosis made on thin needle biopsies, most often in the absence of a palpable abnormality. Treatment choices ranging from surveillance to radical prostatectomy or radiation therapy are largely driven by the pathologic findings in the biopsy specimen. The first part of this review focuses on important morphologic parameters in needle biopsy specimens that are not covered in the accompanying articles. This includes tumor quantification as well as other parameters such a extraprostatic extension, seminal vesicle invasion, perineural invasion, and lymphovascular invasion. For those men who undergo radical prostatectomy, pathologic stage and other parameters are critical in prognostication and in determining the appropriateness of adjuvant therapy. Staging parameters, including extraprostatic extension, seminal vesicle invasion, and lymph node status are discussed here. Surgical margin status is also an important parameter and definitions and reporting of this feature are detailed. Throughout the article the current reporting guidelines published by the College of American Pathologists and the International Collaboration on Cancer Reporting are highlighted.

AB - Prostatic adenocarcinoma remains the most common cancer affecting men. A substantial majority of patients have the diagnosis made on thin needle biopsies, most often in the absence of a palpable abnormality. Treatment choices ranging from surveillance to radical prostatectomy or radiation therapy are largely driven by the pathologic findings in the biopsy specimen. The first part of this review focuses on important morphologic parameters in needle biopsy specimens that are not covered in the accompanying articles. This includes tumor quantification as well as other parameters such a extraprostatic extension, seminal vesicle invasion, perineural invasion, and lymphovascular invasion. For those men who undergo radical prostatectomy, pathologic stage and other parameters are critical in prognostication and in determining the appropriateness of adjuvant therapy. Staging parameters, including extraprostatic extension, seminal vesicle invasion, and lymph node status are discussed here. Surgical margin status is also an important parameter and definitions and reporting of this feature are detailed. Throughout the article the current reporting guidelines published by the College of American Pathologists and the International Collaboration on Cancer Reporting are highlighted.

UR - http://www.scopus.com/inward/record.url?scp=85065315704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065315704&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2017.167

DO - 10.1038/modpathol.2017.167

M3 - Article

VL - 31

SP - S96-S109

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - S1

ER -